Inogen Inc (NAS:INGN)
$ 8.72 0.11 (1.28%) Market Cap: 205.59 Mil Enterprise Value: 105.30 Mil PE Ratio: 0 PB Ratio: 1.07 GF Score: 68/100

Inogen Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript

Mar 23, 2022 / 08:30PM GMT
Release Date Price: $31.54 (-5.34%)
Matt Mishan
KeyBanc Capital Markets - Analyst

Good afternoon. I would like to welcome everybody to the second day of the KeyBanc Life Sciences and MedTech Investor Forum. My name is Matt Mishan; I'm our senior med tech analyst. And I'm pleased to be joined by Inogen, who is represented today by its CEO, Nabil Shabshab; and its CFO, Kristin Caltrider. (Conference Instructions)

Hey, Nabil, thank you very much for joining us. I'll let you introduce the rest of your team. Who is with you today?

Nabil Shabshab
Inogen, Inc. - President, CEO, & Director

Hey, Matt. Good to see you. So in addition to Kristin Caltrider, who's the CFO that joined us a few days ago, only this is her third day. I've got George Parr, who is our Chief Commercial Officer. I've got Stan Glezer, who is our Chief Technology Officer, and Mike Sergesketter is with us, with the role he served as the Interim CFO for the last 2.5 months.

Questions & Answers

Matt Mishan
KeyBanc Capital Markets - Analyst

Okay. Excellent. Let's just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot